ARTICLE | Clinical News
Emisphere enrollment less than expected
September 14, 2000 7:00 AM UTC
EMIS said that it will not complete by year end its double-blind Phase III trial comparing its oral heparin with Lovenox from Aventis (AVE) to treat deep vein thrombosis. The company had initially tar...